Are the TR46/Y121F/T289A Mutations in Azole-Resistant Aspergillosis Patient Acquired or Environmental?
Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Jochem B
http://orcid.org/0000-0003-4031-0778
JB
Buil
Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Jacques F
http://orcid.org/0000-0003-3253-6080
JF
Meis
Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Willem J G
http://orcid.org/0000-0002-5446-2230
WJ
Melchers
Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands paul.verweij@radboudumc.nl.
Paul E
http://orcid.org/0000-0002-8600-9860
PE
Verweij
D000935:Antifungal Agents / Q000494:pharmacology*; D001228:Aspergillosis / Q000382:microbiology*; D001232:Aspergillus fumigatus / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification; D001393:Azoles / Q000494:pharmacology*; D025141:Drug Resistance, Fungal / Q000235:genetics; D004777:Environment; D017809:Fatal Outcome; D005656:Fungal Proteins / Q000235:genetics*; D005659:Fungicides, Industrial; D006801:Humans; D009154:Mutation
D000935:Antifungal Agents; D001393:Azoles; D005656:Fungal Proteins; D005659:Fungicides, Industrial